Seneca Biopharma Reports 2020 First Quarter Results
- Friday, May 15, 2020, 7:19
- PR Newswire
- Add a comment
GERMANTOWN, Md., May 15, 2020 /PRNewswire/ — Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today reported its financial results for the quarter ended March 31, 2020. Business Highlights…
About the Author
admin has written 21653 stories on this site.